Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01507116 · ClinicalTrials.gov registry record

Diabetes Attitudes Wishes and Needs

A clinical trial, sponsored by Novo Nordisk A/S.

Completed
Registry status
8,985
Enrollment target

NCT01507116: Completed study, sponsored by Novo Nordisk A/S.

NCT01507116 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 8,985 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01507116 has completed, sponsored by Novo Nordisk A/S.

COMPLETED
Registry status
8,985 participants
Enrollment target

Study Summary

The study is conducted in Africa, Asia, Europe, Japan, North America and South America. The multinational surveys will explore the experiences and unmet needs of people with diabetes, as well as those of family members of people with diabetes, and of healthcare professionals treating people with diabetes.

Interventions

  • OTHER No treatment given

Trial Details

FieldValue
Enrollment Target 8,985 participants
Start Date 2012-03
Est. Completion 2012-09
Novo Nordisk A/S

431 total trials

What the finished NCT01507116 record still lists

NCT01507116 is an observational study that tracks outcomes without assigning an intervention. Its 8,985 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which No treatment given is the first listed.

NCT01507116 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01507116 about?

NCT01507116 is a clinical study titled "Diabetes Attitudes Wishes and Needs". The study is conducted in Africa, Asia, Europe, Japan, North America and South America. The multinational surveys will explore the experiences and unmet needs of people with diabetes, as well as those of family members of people with diabetes, and of healthcare professionals treating people with di...

What is the current status of trial NCT01507116?

This trial is currently completed. The enrollment target is 8,985 participants. The study started on 2012-03. Estimated completion is 2012-09.

What interventions are being tested in trial NCT01507116?

The interventions under investigation include: No treatment given (OTHER).

Who is sponsoring clinical trial NCT01507116?

This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02000089 · 9,000 participants · Phase 3

    The Cancer of the Pancreas Screening-5 CAPS5)Study

  • NCT05612347 · 8,946 participants · NA

    Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

  • NCT06946355 · 9,119 participants · NA

    Food-based Support for Hospitalized Children and Their Families

  • NCT05336877 · 8,744 participants

    Aveir VR Coverage With Evidence Development Post-Approval Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01507116, the US trial registry maintained by the National Library of Medicine. NCT01507116 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.